AB 1172 (Seizure Emergency Response Act) authorizes adult residential facilities and adult day programs to allow administrators and designated employees who volunteer and complete required training to administer prescribed intranasal emergency antiseizure medication during seizure emergencies. The bill conditions administration on a written, provider-approved seizure action plan, state-issued minimum training standards, and documentation and storage rules drawn from existing Title 22 requirements.
The law matters because it creates a bounded pathway for nonmedical staff to deliver time‑sensitive, life‑saving medication where immediate access to medical personnel may be limited. It pairs that authorization with mandatory training, annual parental/representative authorization, and indemnification plus limited immunity, shifting how facilities, families, and regulators manage seizure emergencies in adult care settings.
At a Glance
What It Does
Permits an administrator or an authorized volunteer at an adult residential facility or adult day program to administer intranasal emergency antiseizure medication when a client’s seizure action plan authorizes it and the staffer has completed state minimum training. The State Department of Social Services must adopt training standards by January 1, 2028, and facilities must keep written plans, records, and pharmacy‑labeled medication on site.
Who It Affects
Adult residential facilities and adult day programs licensed under California Title 22, their administrators and employees who volunteer to be trained, clients with seizure disorders and their authorized representatives, regional centers and health care providers who prepare seizure action plans, and pharmacies that dispense labeled intranasal medication.
Why It Matters
The bill standardizes a delegation pathway for intranasal antiseizure drugs that many facilities have sought but could not formally adopt; it reduces the legal ambiguity that previously discouraged nonmedical staff from acting, while creating new operational obligations around training, documentation, storage, and coordination when no trained staff are available.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
AB 1172 creates the Seizure Emergency Response Act, which authorizes a narrowly defined group of nonmedical staff in two types of licensed adult care settings—adult residential facilities and adult day programs—to give intranasal emergency antiseizure medication when a client experiences a qualifying seizure. The authorization is not automatic: the client or their authorized representative must request the service, and a signed seizure action plan from the client’s health care provider must be on file describing when and how the medication is to be used.
The State Department of Social Services must adopt minimum training standards by January 1, 2028. The bill specifies the training content—recognizing seizure signs, administering or assisting with intranasal medication, basic emergency follow‑up, and written materials—and requires training to be provided at no cost and during regular working hours.
Facilities must retain training documentation in personnel files and keep written materials centrally available for reference.Operational safeguards are woven into the statute: the seizure action plan must include provider verification, dosage, administration method, descriptive triggers for administration, storage instructions, post‑event observation protocols, and emergency contact guidance. Medication must be supplied with the pharmacy label intact.
Facilities must adopt implementing policies, document each dose administered, and maintain plans consistent with existing Title 22 recordkeeping rules. If a facility lacks trained staff, it must notify the requesting client, their representative, or regional center service coordinator to coordinate alternate care.The bill builds in personnel protections as an incentive to volunteer: administrators and authorized volunteers receive written defense and indemnification arrangements from the licensee and a statutory immunity from civil, criminal, and professional review for actions taken in good faith and not for compensation, with carve‑outs for gross negligence, willful misconduct, criminal acts, and certain professional disciplinary contexts.
Volunteers may rescind their offer at any time without retaliation; the facility must inform them of that right and of the liability protections in writing.
The Five Things You Need to Know
The State Department of Social Services must adopt minimum training standards for recognizing and responding to seizures, including intranasal medication administration, by January 1, 2028.
A signed seizure action plan from the client’s health care provider is required before any nonmedical staff may administer intranasal antiseizure medication; that authorization is effective for the calendar year and must be renewed annually.
Training must be provided at no cost to the administrator or authorized volunteer and during their regular working hours, with documentation retained under Title 22 references (Sections 80066 and 82066).
Medication supplied to the facility must be pharmacy‑labeled with the dispensing label intact, and each dose administered must be recorded consistent with Title 22 rules for medication documentation.
Licensees must provide written defense and indemnification to each administrator or authorized volunteer and the statute grants statutory immunity for good‑faith volunteers except for gross negligence, willful misconduct, criminal acts, or acts outside the article’s authorization.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Who and what the law covers
This initial portion defines key terms—administrator, authorized representative, authorized volunteer, licensed facility, health care provider, and seizure action plan—by cross‑reference to existing Title 22 definitions and Business and Professions Code licensing classifications. Practically, that ties the statute into the current regulatory fabric: licensing duties, recordkeeping rules, and professional scopes of practice will govern how the new permissions operate in each facility type.
When nonmedical staff may give intranasal medication
Section 1528.1 sets the gating rules: a facility may allow an administrator or an employee who volunteers (and is authorized by the licensee) to administer intranasal emergency antiseizure medication only upon a client or representative’s request and only during a seizure event identified in the seizure action plan. It also protects employee autonomy by allowing volunteers to rescind at any time and requires licensees to adopt implementing policies to ensure compliance with the client’s individualized plan.
State training standards and delivery logistics
This section directs DSS to adopt minimum training standards by a calendar deadline and to consult epilepsy and medical organizations in doing so. It lists required training elements—recognition, administration/assistance, emergency follow‑up, and written materials—authorizes alignment with school training where appropriate, and requires facilities to provide training free and during work hours. It also mandates central retention of materials and training records, a written notice to volunteers about their rights and indemnity, and a notification duty to clients when no trained staff are available.
Seizure action plan content, storage and documentation
Section 1528.3 prescribes the seizure action plan’s required contents: provider‑signed authorization, medication details (name, dose, route, frequency), explicit triggers for administration, adverse response mitigation, post‑seizure observation protocols, storage instructions, and a plan for coordinating care when trained staff are absent. It ties record retention and medication documentation to specific Title 22 sections and requires pharmacy labeling to remain intact—practical steps to preserve chain‑of‑custody and regulatory compliance.
Defense, indemnification, and limited immunity
This part requires licensees to provide written defense and indemnification consistent with the Government Code’s public liability provisions and grants statutory protections to good‑faith, uncompensated volunteers, trainers, and others complying with the article. It explicitly preserves accountability for gross negligence, willful misconduct, criminal acts, and allows licensing boards to discipline licensed practitioners for unauthorized acts. The section also clarifies that a paid staff member who volunteers under this law is not deemed to be providing compensated medical care.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Clients with seizure disorders who attend adult day programs or live in adult residential facilities — they gain a clearer, facility‑level path to timely administration of intranasal antiseizure medication that may reduce prolonged seizures and emergency transports.
- Authorized representatives and families — they receive a formal, documented mechanism (the seizure action plan) and annual authorization to have nonmedical staff respond to seizure emergencies when immediate medical personnel aren’t available.
- Licensees (adult residential facilities and adult day programs) — they get a statutory framework to adopt emergency seizure protocols and relief from uncertainty about liability if they implement training, documentation, and indemnification requirements.
- Health care providers and regional centers — they benefit from standardized plan elements and clear storage/labeling expectations that make their prescriptions and care instructions actionable in the facility setting.
- Administrators and employees who volunteer — they obtain statutory immunity and written indemnification (subject to exceptions) that lowers legal risk for providing emergency assistance in good faith.
Who Bears the Cost
- Licensees (facilities) — they must develop policies, host and document training, maintain central materials and records consistent with Title 22, ensure proper storage and pharmacy labeling, and may face increased administrative workloads and training costs.
- State Department of Social Services — tasked with convening stakeholders and issuing training standards by a fixed deadline, creating an unfunded regulatory design and oversight responsibility.
- Regional centers/service coordinators — tasked to coordinate care and be notified when a facility lacks trained staff, adding case‑management duties and potentially needing to find alternative providers.
- Insurers and legal departments — indemnity and defense obligations may increase claims exposure or raise premiums for licensees and could prompt insurers to seek stricter policy terms or exclusions.
- Licensed health care professionals in facilities — while the law protects volunteers, licensed professionals remain subject to licensing board discipline for acts beyond the statute’s authorization, creating potential professional risk calculation.
Key Issues
The Core Tension
The central dilemma is whether to prioritize rapid access to a life‑saving intervention by delegating it to trained nonmedical staff or to prioritize traditional medical oversight and liability protection; the bill aims for a middle path—authorization plus training and limited immunity—but leaves unresolved how to operationalize training, staffing, funding, and the legal lines that separate good‑faith help from culpable medical error.
The bill trades immediacy for a set of bureaucratic guardrails: it allows nonmedical staff to act but only after provider‑signed plans, specified training, and documentation. That combination reduces ambiguity but raises implementation questions—who pays for training and oversight, how small facilities will sustain staffing to ensure trained coverage, and how regional centers will manage notification and alternate care when no trained staff are available.
The requirement that medication carry an intact pharmacy label and that dose administration be recorded under Title 22 helps preserve chain‑of‑custody and regulatory consistency, but it also creates operational friction (e.g., lost or expired medication, off‑site refills) that facilities must manage.
Liability protections are central to the bill’s practical effect, but they are not absolute. The immunity excludes gross negligence, willful misconduct, criminal acts, and does not prevent licensing boards from disciplining licensed professionals who act outside the statute’s narrow authorization.
Those carve‑outs will be litigated and interpreted in practice: facilities, insurers, and counsel will push to define the boundary between a covered good‑faith intervention and gross negligence. The statute contemplates volunteers who are paid staff; that creates potential tensions with employment law and compensation expectations that the bill does not address, and it may affect willingness to volunteer in practice.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.